TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX)

26 filings reported holding TENX - TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q4 2024.
TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.36M shares of 25M outstanding shares and own 5.46% of the company stock.
Largest 10 shareholders include BVF INC/IL (340K shares), Vivo Capital, LLC (208K shares), VR Adviser, LLC (208K shares), JANUS HENDERSON GROUP PLC (167K shares), Velan Capital Investment Management LP (83.3K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (83.3K shares), MORGAN STANLEY (74.4K shares), Vestal Point Capital, LP (55.2K shares), ADAR1 Capital Management, LLC (34.7K shares), and MILLENNIUM MANAGEMENT LLC (26.8K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.